Seouleaguer Co (043710) Fair Value & Analysis
Consumer Non-Cyclicals · KR · Market cap 51.5B KRW
Fair value as of: Jul 20, 2026
From 1 valuation models · updated 21 days ago
Share price +2.5% over the past month.
Below-average quality, and screening another 76% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (1,211 KRW). The favourable scenario is already priced in.
- Weak quality (29/100) and above fair value at the same time, the margin of safety is missing on both counts.
- The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
- A fairly wide model range (605.44 KRW to 1,211 KRW) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 20, 2026.
How to read this chart
60‑month range 2,515 KRW – 10,225 KRW · fair‑value band 605.44 KRW – 1,211 KRW · the 3,445 KRW price screens above the 811.29 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 20, 2026.
Analysis
Seouleaguer Co (043710) currently trades at 3,445 KRW, while our model-based Fair Value estimate is 811.29 KRW, implying the stock looks roughly 76.5% overvalued today. The Quality Score stands at 29/100 (below-average quality), in the Consumer Non-Cyclicals sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
Revenue grew 1.7% year over year. Net debt stands at 140B KRW. Fundamentals as of Jul 20, 2026
Our scenario range runs from 605.44 KRW (bear case) to 1,211 KRW (bull case); at 3,445 KRW, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 51% below its 52-week high, currently below its 200-day average. For context, the median of 10 Consumer Non-Cyclicals peers we cover trades at -18% fair-value upside, at -76%, 043710 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 1 models by family
Notify me when 043710 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
Figures from reported company fundamentals · as of Jul 20, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 25 · Market factors (momentum, volatility) 19
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Seouleaguer Co., Ltd., a medical beauty care platform company, provides hospital management support services in South Korea. The company was formerly known as Rocketmobile Co., Ltd. and changed its name to Seouleaguer Co., Ltd. in July 2016. Seouleaguer Co., Ltd. was founded in 1991 and is headquartered in Seoul, South Korea.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Seouleaguer Co reported revenue of 35.7B KRW in FY2025 versus 14.9B KRW in FY2021, a compound +24.4%/yr. Reported net income was −8.7B KRW in FY2025.
043710 screens 76% overvalued. Compare with PGOLD →
Peer Group
Consumer Discretionary · 3552 stocks
How this stock ranks against its sector: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median. (Industry “Food & Drug Retailing” was too small, so the broader sector is used.)
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Food & Drug Retailing stocks, each showing price versus our Fair Value estimate (as of Jul 20, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| PGOLD PGOLD | 39.30 PHP | 62.75 PHP | +60% |
| RRHI RRHI | 38.00 PHP | 43.51 PHP | +15% |
| KEEPR KEEPR | 1.86 PHP | 6.15 PHP | +231% |
| Gimat Magazacilik Sanayi Ve Ticaret A.S. GMTAS | 46.70 TRY | 8.96 TRY | -81% |
| Curexo Inc 060280 | 8,000 KRW | 1,147 KRW | -86% |
| FRUIT FRUIT | 0.6700 PHP | 0.5500 PHP | -18% |
| COSCO COSCO | ₹208.00 | ₹51.24 | -75% |
| FB FB | 49.00 PHP | 49.03 PHP | +0% |
| JGS JGS | 25.00 PHP | 20.51 PHP | -18% |
| URC URC | 61.20 PHP | 47.86 PHP | -22% |
Compare Seouleaguer Co with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
Frequently asked questions
Is Seouleaguer Co (043710) overvalued or undervalued?
What is the fair value of 043710?
What is the quality score of 043710?
What is the net profit margin of 043710?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Seouleaguer Co and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.